STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
659
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $422.7K priced
What the filings say about CTAS
Insiders, 180 days
-$2.7M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-09-23
Cintas insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CINTAS CORP insiders sold a net $2.7M of stock across 35 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Apr 20, 2026.
The trade is 19.4% of the 22,448 shares held after it.
1 other insider sold within 30 days.
659 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director TYSOE RONALD W sold about $872.2K of CTAS on Jul 22, 2026; 1 other insider sold within 30 days and 659 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Oct 13, 2023.
The trade is 34.4% of the 26,592 shares held after it.
1 other insider sold within 30 days.
659 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Barstad Melanie W. sold about $1.9M of CTAS on Jul 16, 2026; 1 other insider sold within 30 days and 659 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Apr 14, 2025.
The trade is 23.2% of the 21,945 shares held after it.
1 other insider sold within 30 days.
659 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director TYSOE RONALD W sold about $1.1M of CTAS on Jul 30, 2025; 1 other insider sold within 30 days and 659 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Apr 14, 2025.
The trade is 23.2% of the 21,945 shares held after it.
1 other insider sold within 30 days.
659 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director TYSOE RONALD W sold about $1.1M of CTAS on Jul 30, 2025; 1 other insider sold within 30 days and 659 funds added in the latest 13F quarter.
35 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CTAS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
TYSOE RONALD W
Filed 2026-07-22
$872.2K
Barstad Melanie W.
Filed 2026-07-16
$1.9M
CTAS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Value Line Select Core Fund
$17.0M position · as of 2026-06-30
5.8%
NYLIM WMC Enduring Capital Fund
$16.2M position · as of 2026-07-31
4.7%
FAM DIVIDEND FOCUS FUND
$27.1M position · as of 2026-06-30
4.3%
FULLERTHALER BEHAVIORAL UNCONSTRAINED EQUITY
$40.1M position · as of 2026-06-30
4.2%
AB Concentrated Growth Fund
$18.7M position · as of 2026-06-30
4.0%
TimesSquare Quality Mid Cap Growth ETF
$1.4M position · as of 2026-05-31
3.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Cintas Corporation Partners Pac
Cycle 2026 · $52K spent
$92.2K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Todd M. Schneider
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$12.2M
$484.0K
$3.2M
+103%
+52%
2024
$9.2M
$34.6M
$2.6M
+166%
+53%
2023
$8.8M
$34.9M
$3.4M
+97%
+22%
2022
$7.6M
$19.7M
$2.8M
+36%
+8%
2021
$7.8M
$18.3M
$2.7M
+14%
-2%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $2.7M sold by insiders over 180 days, 659 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$11.6B
four quarters, 2025-09-01 to 2026-08-31
Revenue, TTM CTAS
FY May 2026
$11.3B
FY May 2025
$10.3B
FY May 2024
$9.6B
FY May 2023
$8.8B
FY May 2022
$7.9B
Aug 2026
$3.0B
May 2026
$2.9B
Feb 2026
$2.8B
Nov 2025
$2.8B
Aug 2025
$2.7B
May 2025
$2.7B
Feb 2025
$2.6B
Nov 2024
$2.6B
At each fiscal year end
Single quarter
Net margin, TTM
+17.8%
net income over revenue, 2025-09-01 to 2026-08-31
Net margin, TTM CTAS
FY May 2026
+17.8%
FY May 2025
+17.5%
FY May 2024
+16.4%
FY May 2023
+15.3%
FY May 2022
+15.7%
Aug 2026
+18.3%
May 2026
+17.6%
Feb 2026
+17.7%
Nov 2025
+17.7%
Aug 2025
+18.1%
May 2025
+16.8%
Feb 2025
+17.8%
Nov 2024
+17.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.0B
operating cash flow minus capex, 2025-09-01 to 2026-08-31
Free cash flow, TTM CTAS
FY May 2026
$1.9B
FY May 2025
$1.8B
FY May 2024
$1.7B
FY May 2023
$1.3B
FY May 2022
$1.3B
Aug 2026
$464.8M
May 2026
$613.1M
Feb 2026
$530.6M
Nov 2025
$425.0M
Aug 2025
$312.5M
May 2025
$525.7M
Feb 2025
$520.6M
Nov 2024
$343.3M
At each fiscal year end
Single quarter
Debt to equity
0.47x
long-term 2026-08-31 plus current 2026-08-31; equity 2026-08-31
Debt to equity CTAS
FY May 2026
0.47x
FY May 2025
0.52x
FY May 2024
0.57x
FY May 2023
0.64x
FY May 2022
0.85x
Aug 2026
0.47x
May 2026
0.47x
Feb 2026
0.55x
Nov 2025
0.67x
Aug 2025
0.51x
May 2025
0.52x
Feb 2025
0.54x
Nov 2024
0.62x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.00x
TTM operating cash flow over long-term 2026-08-31 plus current 2026-08-31
Cash flow to debt CTAS
FY May 2026
0.94x
FY May 2025
0.89x
FY May 2024
0.84x
FY May 2023
0.64x
FY May 2022
0.55x
Aug 2026
1.00x
May 2026
0.94x
Feb 2026
0.83x
Nov 2025
0.74x
Aug 2025
0.87x
May 2025
0.89x
Feb 2025
0.89x
Nov 2024
0.84x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+41.4%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on equity CTAS
FY May 2026
+40.7%
FY May 2025
+40.3%
FY May 2024
+38.4%
FY May 2023
+37.6%
FY May 2022
+35.3%
Aug 2026
+41.4%
May 2026
+40.7%
Feb 2026
+41.3%
Nov 2025
+43.4%
Aug 2025
+42.2%
May 2025
+40.3%
Feb 2025
+40.3%
Nov 2024
+41.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+20.1%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on assets CTAS
FY May 2026
+19.7%
FY May 2025
+19.1%
FY May 2024
+17.7%
FY May 2023
+16.2%
FY May 2022
+15.1%
Aug 2026
+20.1%
May 2026
+19.7%
Feb 2026
+19.5%
Nov 2025
+19.5%
Aug 2025
+19.6%
May 2025
+19.1%
Feb 2025
+19.1%
Nov 2024
+18.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+29.7%
operating income after a 20.7% effective tax rate, over long-term 2026-08-31 plus current 2026-08-31 plus average of 2025-08-31 and 2026-08-31 minus cash
Return on invested capital CTAS
FY May 2026
+29.5%
FY May 2025
+28.5%
FY May 2024
+26.0%
FY May 2023
+24.1%
FY May 2022
+21.8%
Aug 2026
+29.7%
May 2026
+29.5%
Feb 2026
+28.3%
Nov 2025
+27.4%
Aug 2025
+28.8%
May 2025
+28.5%
Feb 2025
+27.6%
Nov 2024
+26.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+33.2%
operating income (EBIT proxy) over average of 2025-08-31 and 2026-08-31 minus current liabilities
Return on capital employed CTAS
FY May 2026
+32.5%
FY May 2025
+30.4%
FY May 2024
+28.2%
FY May 2023
+25.7%
FY May 2022
+24.4%
Aug 2026
+33.2%
May 2026
+32.5%
Feb 2026
+31.5%
Nov 2025
+32.2%
Aug 2025
+31.4%
May 2025
+30.4%
Feb 2025
+30.0%
Nov 2024
+30.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
44.20x
close 2026-10-23 over four quarters of diluted EPS, 2025-09-01 to 2026-08-31
P/E, trailing CTAS
FY May 2026
34.88x
FY May 2025
51.36x
FY May 2024
44.72x
FY May 2023
36.32x
FY May 2022
8.55x
Aug 2026
39.80x
May 2026
34.88x
Feb 2026
42.43x
Nov 2025
40.18x
Aug 2025
46.57x
May 2025
51.36x
Feb 2025
48.03x
Nov 2024
54.41x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$91.2B
market value at close 2026-10-23 on 2026-09-30 shares, plus long-term 2026-08-31 plus current 2026-08-31, minus cash 2026-08-31
Enterprise value CTAS
FY May 2026
$70.7B
FY May 2025
$93.6B
FY May 2024
$19.3B
FY May 2023
$14.4B
FY May 2022
$12.9B
Aug 2026
$82.9B
May 2026
$70.7B
Feb 2026
$82.9B
Nov 2025
$77.5B
Aug 2025
$86.9B
May 2025
$93.6B
Feb 2025
$86.0B
Nov 2024
$93.6B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.3%
TTM free cash flow over market value at close 2026-10-23
FCF yield CTAS
FY May 2026
+2.7%
FY May 2025
+1.9%
FY May 2024
+9.6%
FY May 2023
+10.5%
FY May 2022
+12.7%
Aug 2026
+2.5%
May 2026
+2.7%
Feb 2026
+2.2%
Nov 2025
+2.4%
Aug 2025
+2.0%
May 2025
+1.9%
Feb 2025
+2.2%
Nov 2024
+2.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
3.56x
P/E over trailing EPS growth of 12%: four quarters to 2026-08-31 against the four to 2025-08-31
PEG, trailing CTAS
FY May 2026
3.08x
FY May 2025
3.14x
FY May 2024
2.69x
FY May 2023
n/a
FY May 2022
0.62x
Aug 2026
3.21x
May 2026
3.08x
Feb 2026
4.36x
Nov 2025
3.47x
Aug 2025
3.35x
May 2025
3.14x
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CTAS ranks highest on profitability (92nd percentile) and institutional and government (87th), and lowest on insider conviction (14th), among Consumer Goods peers.
Profitability
92
Inputs
Return on equity+41.4% · 93 pct, sector of 105
Return on assets+20.1% · 96 pct, sector of 124
Return on invested capital+29.7% · 80 pct, sector of 51
Return on capital employed+33.2% · 97 pct, sector of 108
Financial health
57
Inputs
Debt to equity0.47x · 39 pct, sector of 112
Cash flow to debt1.00x · 75 pct, sector of 96
Growth
67
Inputs
Revenue growth, YoY+8.9% · 67 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
14
Inputs
Net Form 4 buying (codes P and S), 180d-$2.7M · 28 pct, sector of 80
Insider buyers, 180d0 · 0 pct, sector of 80
Institutional and government
87
Inputs
Funds adding, latest quarter659 · 96 pct, sector of 123
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$1.5M · 77 pct, universe of 1,063
Risk and compliance
53
Inputs
Short interest, % of float+3.7% · 51 pct, sector of 157
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 102
New text in Risk Factors, latest 10-K+34.1% · 7 pct, sector of 111
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CTAS filings, in plain words
Are Cintas insiders buying or selling CTAS?
In the 180 days to 2026-10-27, Cintas insiders were net sellers, a net $2.7M across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded CTAS?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Valerie Hoyle dated 2025-09-23.
Read the full summary
In the 180 days to 2026-10-27, Cintas insiders were net sellers of CTAS, a net $2.7M across purchases and sales reported on Form 4 by 2 sellers. Members of Congress have disclosed trades in CTAS, none in the last year; the latest on record is a sale by Valerie Hoyle dated 2025-09-23. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.